Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Relationship Between Statin Type and Responsiveness to Clopidogrel in Patients Treated with Percutaneous Coronary Intervention: A Subgroup Analysis of the CILON-T Trial

Full metadata record
DC Field Value Language
dc.contributor.authorSuh, Jung-Won-
dc.contributor.authorCha, Myung-Jin-
dc.contributor.authorLee, Seung-Pyo-
dc.contributor.authorChae, In-Ho-
dc.contributor.authorBae, Jang-Ho-
dc.contributor.authorKwon, Taek-Geun-
dc.contributor.authorBae, Jang-Whan-
dc.contributor.authorCho, Myeong-Chan-
dc.contributor.authorRha, Seung-Woon-
dc.contributor.authorKim, Hyo-Soo-
dc.date.accessioned2021-09-05T17:20:42Z-
dc.date.available2021-09-05T17:20:42Z-
dc.date.created2021-06-15-
dc.date.issued2014-
dc.identifier.issn1340-3478-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/101183-
dc.description.abstractAim: To compare the responsiveness to clopidogrel in patients who were prescribed two different types of statins, atorvastatin vs. rosuvastatin, following percutaneous coronary intervention. Methods: A total of 915 patients were randomized according to the antiplatelet therapy strategy in the CILON-T trial. In this subgroup analysis, we included patients who took atorvastatin (20 mg/day, n=295) or rosuvastatin (10 mg/day, n=261) during the entire study period and underwent measurement of the P2Y12 reaction unit (PRU) values at both discharge and six months. We compared the P2Y12 reaction unit (PRU) values at six months and investigated the relationship between the genotypes of cytochrome P450 (CYP) 3A4, 3A5 and 2C19 with the PRU values at six months in both groups. Results: The baseline characteristics did not differ between the groups. There were no significant differences in the PRU values at discharge (atorvastatin 221.0 +/- 87.3 vs. rosuvastatin 217.1 +/- 84.7, p=0.59). However, the rosuvastatin group had higher PRU values than the atorvastatin group at six months (atorvastatin 226.4 +/- 79.3 vs. rosuvastatin 241.5 +/- 88.2, p=0.033). In the genotype analysis, the number of CYP2C19 loss-of-function (LOF) alleles (*2 or *3) was positively associated with a higher PRU value in both statin groups, and there were no significant interactions regarding the PRU values between the number of CYP 2C19 LOF alleles and the type of statin (p for interaction=0.56). In the multivariate analysis, the use of rosuvastatin was a significant predictor of a PRU value of >273 (the highest tertile) (OR 1.67, 95% confidence interval 1.05-2.65, p=0.031). Conclusions: Rosuvastatin is associated with high on-treatment platelet reactivity compared with atorvastatin following the coadministration of clopidogrel for six months. Further studies are therefore warranted to clarify the mechanism underlying this relationship.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherJAPAN ATHEROSCLEROSIS SOC-
dc.subjectTREATMENT PLATELET REACTIVITY-
dc.subjectANTIPLATELET THERAPY-
dc.subjectCLINICAL-OUTCOMES-
dc.subjectHEART-DISEASE-
dc.subjectATORVASTATIN-
dc.subjectINHIBITION-
dc.subjectCILOSTAZOL-
dc.subjectROSUVASTATIN-
dc.subjectASSAY-
dc.subjectPHARMACOLOGY-
dc.titleRelationship Between Statin Type and Responsiveness to Clopidogrel in Patients Treated with Percutaneous Coronary Intervention: A Subgroup Analysis of the CILON-T Trial-
dc.typeArticle-
dc.contributor.affiliatedAuthorRha, Seung-Woon-
dc.identifier.doi10.5551/jat.19265-
dc.identifier.scopusid2-s2.0-84894416564-
dc.identifier.wosid000335459200009-
dc.identifier.bibliographicCitationJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, v.21, no.2, pp.140 - 150-
dc.relation.isPartOfJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS-
dc.citation.titleJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS-
dc.citation.volume21-
dc.citation.number2-
dc.citation.startPage140-
dc.citation.endPage150-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaCardiovascular System & Cardiology-
dc.relation.journalWebOfScienceCategoryPeripheral Vascular Disease-
dc.subject.keywordPlusTREATMENT PLATELET REACTIVITY-
dc.subject.keywordPlusANTIPLATELET THERAPY-
dc.subject.keywordPlusCLINICAL-OUTCOMES-
dc.subject.keywordPlusHEART-DISEASE-
dc.subject.keywordPlusATORVASTATIN-
dc.subject.keywordPlusINHIBITION-
dc.subject.keywordPlusCILOSTAZOL-
dc.subject.keywordPlusROSUVASTATIN-
dc.subject.keywordPlusASSAY-
dc.subject.keywordPlusPHARMACOLOGY-
dc.subject.keywordAuthorAtorvastatin-
dc.subject.keywordAuthorRosuvastatin-
dc.subject.keywordAuthorClopidogrel-
dc.subject.keywordAuthorPlatelet function-
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > Department of Biomedical Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Rha, Seung Woon photo

Rha, Seung Woon
의과학과
Read more

Altmetrics

Total Views & Downloads

BROWSE